What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Tick-Borne Diseases in Dogs: Comprehensive Review of Common Pathogens, Clinical Syndromes, and Management

Introduction

Tick-borne diseases represent a significant and growing portion of canine infectious disease caseloads worldwide. The obligate hematophagous feeding behavior of ixodid ticks facilitates the transmission of a diverse array of bacterial, protozoal, and viral pathogens into the canine host. This review systematically examines the most clinically relevant tick-borne pathogens affecting domestic dogs, with emphasis on their epidemiology, host-pathogen interactions, clinical manifestations, diagnostic approaches, and therapeutic strategies. Understanding the biophysical and immunological mechanisms underlying these infections is critical for effective clinical management and prevention. For a general perspective on tick-borne illness in dogs, readers may refer to Tick-Borne Illness in Dogs: Comprehensive Review of Common Pathogens and Clinical Syndromes.

Epidemiology and Tick Vectors

The geographic distribution of tick-borne diseases in dogs closely mirrors the distribution of their vector tick species. Primary vectors include Rhipicephalus sanguineus (brown dog tick), Dermacentor variabilis (American dog tick), Dermacentor andersoni (Rocky Mountain wood tick), Ixodes scapularis (black-legged tick), Ixodes pacificus (western black-legged tick), and Amblyomma americanum (lone star tick). Climate change, urbanization, and increased wildlife-livestock-dog interface have expanded the endemic ranges of these vectors. A detailed discussion of tick biology and control is available in Livestock Tick Infestations: Identification, Impact on Production, and Control Strategies.

Transmission dynamics are influenced by tick life cycle, feeding duration, and pathogen replication within the tick salivary glands and midgut. For example, Borrelia burgdorferi requires approximately 36 to 48 hours of attachment before transmission occurs, whereas Anaplasma phagocytophilum and Ehrlichia canis can be transmitted within 24 hours of attachment. Co-infections are common due to shared tick vectors and overlapping geographic ranges, complicating clinical presentation and diagnosis.

Major Pathogens and Clinical Syndromes

The following table summarizes the primary tick-borne pathogens of canine relevance, their vectors, major clinical syndromes, and diagnostic targets.

Ehrlichiosis (Canine Monocytic Ehrlichiosis)

Ehrlichia canis is an obligate intracellular Gram-negative bacterium that infects monocytes and macrophages. Following inoculation through tick saliva, the bacteria disseminate via the lymphatics and blood to the spleen, liver, and bone marrow. Clinical presentation proceeds through three phases: acute (fever, lethargy, thrombocytopenia), subclinical (persistent infection without overt signs), and chronic (pancytopenia, bleeding diathesis, polyarthritis, and renal disease). Laboratory abnormalities include non-regenerative anemia, thrombocytopenia, hyperglobulinemia, and mild to moderate leukopenia. Bone marrow examination may reveal myeloid hyperplasia or hypoplasia. Diagnosis is confirmed by serology (IFA or ELISA detecting antibodies to p30/p30-1 proteins) or PCR targeting the 16S rRNA or p28 genes. Cross-reactivity with other Ehrlichia spp. must be considered.

Anaplasmosis

Anaplasmosis in dogs is caused primarily by Anaplasma phagocytophilum (granulocytic anaplasmosis) and less commonly by Anaplasma platys (infectious cyclic thrombocytopenia). A. phagocytophilum infects neutrophils, leading to fever, lethargy, polyarthritis, and thrombocytopenia. Clinical signs often resemble those of ehrlichiosis but tend to be more acute and self-limiting. Neurologic signs (ataxia, seizures) are occasionally reported. A. platys causes cyclic thrombocytopenia with mild to moderate clinical signs, often subclinical in many dogs. A deeper discussion of this pathogen in both companion animals and livestock can be found in Anaplasma phagocytophilum in Livestock and Companion Animals: Diagnostics and Tick-Borne Epidemiology and Anaplasma marginale in Cattle: Tick Transmission Dynamics, Diagnostic Tests, and Herd-Level Control.

Diagnostic approach for anaplasmosis: Detection of morulae (basophilic intracytoplasmic inclusions) in neutrophils or platelets on Giemsa-stained blood smears is suggestive but lacks sensitivity. Serologic testing using IFA or ELISA for A. phagocytophilum antibodies (detecting antibodies to p44 protein) is widely available. PCR amplification of the 16S rRNA or ankA gene offers high sensitivity and specificity, particularly in acute cases before seroconversion. Quantitative PCR is used to monitor response to therapy.

Treatment of anaplasmosis: Doxycycline (10 mg/kg orally once daily for 14 to 28 days) remains the first-line therapy. Clinical improvement is usually rapid (24 to 48 hours), but hematologic abnormalities may take weeks to resolve. In cases of severe thrombocytopenia, supportive care with fluid therapy and, rarely, platelet transfusions may be indicated. Relapse is uncommon if therapy is completed.

Babesiosis

Canine babesiosis is caused by several protozoan species of the genus Babesia. Large Babesia species (B. canis, B. vogeli, B. rossi) are transmitted by Dermacentor and Rhipicephalus ticks, while small Babesia species (B. gibsoni, B. conradae, B. vulpes) may also be transmitted vertically or through blood transfusion. The parasite invades erythrocytes, leading to hemolytic anemia, hemoglobinuria, fever, and splenomegaly. Severe cases may present with disseminated intravascular coagulation, acute kidney injury, or hepatoencephalopathy. Diagnostic confirmation requires visualization of intraerythrocytic piroplasms on blood smear or PCR targeting the 18S rRNA gene. Serologic tests (IFA, ELISA) are available but cannot distinguish active from past infection. For an overview of piroplasms in wildlife, refer to Tick-Borne Parasites in White-Tailed Deer: Babesia and Theileria Prevalence, PCR-Based Surveillance, and Impact on Livestock Interface.

Lyme Borreliosis

Borrelia burgdorferi sensu stricto is the primary agent of Lyme disease in dogs in North America. After transmission via Ixodes ticks, the spirochete initially replicates in the skin before disseminating hematogenously to joints, kidneys, and other tissues. Most infected dogs remain asymptomatic; clinical disease manifests as acute onset of fever, lameness (often shifting leg lameness due to polyarthritis), lymphadenopathy, and lethargy. A minority of dogs develop Lyme nephritis, a severe immune-complex glomerulonephritis with poor prognosis. Diagnosis relies on detection of antibodies to the C6 peptide (a conserved region of VlsE protein) using ELISA, which differentiates natural infection from vaccination. PCR on synovial fluid or renal tissue can detect spirochete DNA but is less sensitive due to low bacterial load. Serologic cross-reactivity with Leptospira spp. is not observed with C6-based tests. Readers should also consult Lyme Disease in Dogs: Borrelia burgdorferi Serological and Molecular Testing in Endemic Regions.

Rocky Mountain Spotted Fever

Rickettsia rickettsii, an obligate intracellular bacterium, targets vascular endothelial cells, causing widespread vasculitis. Clinical signs include fever, petechiation/ecchymosis (due to thrombocytopenia and vasculitis), peripheral edema, neurologic deficits, and acute kidney injury. Mortality in untreated cases can be high. Diagnosis is often presumptive based on clinical signs and response to doxycycline. Acute and convalescent serology (IFA) can confirm infection. PCR on whole blood or skin biopsy is available but sensitivity is highest during the acute febrile phase.

Diagnostic Approaches

Accurate diagnosis of tick-borne diseases requires a multi-modal approach integrating signalment, history (tick exposure, travel), physical examination, hematologic and biochemical parameters, and specific laboratory testing.

Hematologic and biochemical markers:

Thrombocytopenia is a common finding across many tick-borne infections, particularly ehrlichiosis and anaplasmosis.
Anemia (non-regenerative or hemolytic) suggests babesiosis or chronic ehrlichiosis.
Hyperglobulinemia (especially polyclonal gammopathy) is classic for chronic E. canis infection.
Proteinuria (urine protein-to-creatinine ratio) should be assessed in any dog suspected of Lyme nephritis.

Cytology: Examination of stained blood smears (Giemsa or Diff-Quik) can reveal morulae in monocytes (E. canis), neutrophils (A. phagocytophilum), platelets (A. platys), and intraerythrocytic piroplasms (Babesia spp.). Given low sensitivity in low-level parasitemia, cytology should be combined with molecular testing.

Serology: Indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) are widely used. Point-of-care ELISA kits (e.g., C6 peptide for Lyme, p30/p30-1 for E. canis) provide rapid results but cannot distinguish active from past infection. Seroconversion typically occurs 7 to 21 days post-infection. For detailed methodology, see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus (applicable principles apply to canine serology).

Molecular diagnostics: Polymerase chain reaction (PCR) offers high sensitivity and specificity for detecting pathogen DNA in whole blood, buffy coat, synovial fluid, or tissue specimens. Real-time PCR assays can provide quantification of pathogen burden. Species-specific primers targeting 16S rRNA (for Ehrlichia, Anaplasma), 18S rRNA (for Babesia), gltA (for Rickettsia), and ospA (for Borrelia) are standard. PCR is particularly useful in acute infections before seroconversion and in monitoring treatment efficacy.

Advanced diagnostics: High-throughput sequencing (e.g., metagenomic next-generation sequencing) is emerging as a tool for detecting co-infections and novel pathogens but is not yet routine in clinical practice.

Diagnostic Workflow Decision Tree

graph TD
    A[Clinical suspicion of tick-borne disease based on history, signs, CBC, biochemistry], > B{Thrombocytopenia present?}
    B, Yes, > C[Examine blood smear for morulae in monocytes, neutrophils, platelets]
    B, No, > D[Examine blood smear for intraerythrocytic piroplasms]
    C, > E{Morulae detected?}
    E, Yes, > F[PCR for Ehrlichia/Anaplasma species]
    E, No, > G[Serology (IFA/ELISA) for Ehrlichia & Anaplasma + PCR]
    D, > H{Piroplasms detected?}
    H, Yes, > I[PCR for Babesia species (18S rRNA)]
    H, No, > J[Clinical signs suggest Lyme or RMSF?]
    J, Yes, > K[C6 peptide ELISA for Borrelia + serology for Rickettsia]
    J, No, > L[Broader PCR panel: includes Ehrlichia, Anaplasma, Babesia, Borrelia, Rickettsia]
    F & G & I & K & L, > M[Diagnosis confirmed?]
    M, Yes, > N[Initiate appropriate treatment; consider doxycycline for bacterial, antiprotozoal for Babesia]
    M, No, > O[Re-evaluate; consider alternative diagnoses (e.g., immune-mediated disease, other infections)]

Treatment Protocols

Antibiotic therapy for bacterial pathogens: Doxycycline (10 mg/kg PO q24h for 28 days) is the drug of choice for E. canis, A. phagocytophilum, A. platys, and R. rickettsii. For Lyme borreliosis, doxycycline for 30 days is standard; amoxicillin or cefovecin are alternatives but less effective against intracellular organisms. Tetracyclines should be avoided in puppies due to bone and tooth discoloration; chloramphenicol or amoxicillin may be substituted in young animals.

Antiprotozoal therapy for babesiosis: Imidocarb dipropionate (5-7 mg/kg IM once, repeated after 14 days) is effective against large Babesia spp. For small Babesia spp. (e.g., B. gibsoni), a combination of atovaquone (13.5 mg/kg PO q8h) and azithromycin (10 mg/kg PO q24h) for 10 days has shown efficacy. Atovaquone resistance has been reported. Supportive care includes fluid therapy, blood transfusion for severe anemia, and antioxidants.

Supportive care: Intravenous fluids, antiemetics, hematinics (e.g., erythropoietin in chronic ehrlichiosis), and pain management (NSAIDs with caution in thrombocytopenic patients) are important adjuncts. Glucocorticoids may be considered for immune-mediated complications (e.g., immune-mediated hemolytic anemia secondary to babesiosis, Lyme nephritis) but should be used judiciously.

Treatment monitoring: Repeat CBC and biochemistry at 7 days and 30 days post-treatment. Serology may remain positive for months after successful treatment. PCR negativity at 30 days is a good indicator of microbial clearance. For chronic ehrlichiosis, long-term doxycycline (up to 8 weeks) may be required.

Prevention and Control

Effective prevention relies on combined vector control and vaccination. The approach is similar to strategies for Canine Heartworm (Dirofilaria immitis) Disease: Current Diagnostic and Therapeutic Protocols and Livestock Tick Infestations.

Acaricides: Topical formulations (fipronil, permethrin, imidacloprid), oral isoxazolines (afoxolaner, fluralaner, sarolaner), and collars (e.g., flumethrin-impregnated) provide sustained tick-kill activity. Isoxazolines have rapid onset and good safety profile but require veterinary prescription.
Tick checks: Daily removal of attached ticks reduces pathogen transmission risk but cannot prevent infection from rapid-transmitting agents like Ehrlichia and Anaplasma.
Vaccination: A Lyme bacterin vaccine exists for dogs in endemic areas. It does not prevent infection but reduces clinical disease and renal complications. Vaccination for ehrlichiosis or anaplasmosis is not available.
Environmental management: Mowing tall grass, reducing wildlife access, and using tick control products in kennels can lower tick burdens.

Conclusion

Tick-borne diseases in dogs encompass a complex and clinically challenging group of infections caused by diverse intracellular pathogens. Successful management requires a high index of suspicion in endemic areas, early use of sensitive diagnostics (blood smear cytology, serology, and PCR), and prompt initiation of appropriate antimicrobial therapy. Anaplasmosis, ehrlichiosis, babesiosis, Lyme borreliosis, and RMSF each present with overlapping but distinct clinical features. Prevention through rigorous tick control remains the cornerstone of population-level disease reduction. Ongoing surveillance and research into emerging tick-borne agents, as well as antimicrobial resistance patterns in protozoal infections, are needed to refine future therapeutic guidelines.

References

Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Saunders/Elsevier; 2012.
Little SE. Ticks and Tick-Borne Diseases of Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice. 2010;40(6):1121-1134.
Ettinger SJ, Feldman EC, Côté E, eds. Textbook of Veterinary Internal Medicine. 8th ed. St. Louis, MO: Elsevier; 2017.
Kidd L, Breitschwerdt EB. Transmission times and tick-borne diseases. Veterinary Clinics of North America: Small Animal Practice. 2003;33(4):937-946.
Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. Journal of Veterinary Internal Medicine. 2002;16(3):309-315.